Finasteride Dosing for Young Adults (Ages 18 to 29): What You Need to Know

What is the finasteride dose for a man in his 20s?

Propecia, the 1 mg tablet (finasteride 1 mg), is indicated for male pattern hair loss (androgenetic alopecia) in men only, and efficacy in bitemporal recession — the receding temples — has not been established [1]. The recommended dose is one tablet once daily, with or without meals [1]. Daily use for three months or more is usually necessary before benefit is observed, continued use is needed to sustain it, and withdrawal leads to reversal of the effect within 12 months [1].

The dose does not change with age inside the adult range: the label describes a single regimen of 1 mg once daily [1]. A 1 mg tablet reaches about 65% suppression of serum DHT within 24 hours of dosing [1].

How much hair growth did 1 mg a day produce in the trials?

In Kaufman et al. (J Am Acad Dermatol 1998), two 1-year placebo-controlled trials in 1,553 men aged 18 to 41 with male pattern hair loss, comparing finasteride 1 mg daily with placebo, with 1,215 men continuing into blinded 12-month extensions [2]. Hair count in a 1-inch (5.1 cm²) circle of balding vertex scalp, starting from a baseline of 876 hairs, was 107 hairs higher than placebo at 1 year and 138 higher at 2 years (P<0.001) [2]. Men on placebo kept losing hair over the same period [2]. The Propecia label describes three double-blind, randomized, 12-month studies in 1,879 men, two in vertex hair loss and one in anterior mid-scalp hair loss [1].

Does the 5 mg dose ever apply at 18 to 29?

Proscar 5 mg once daily is the dose for symptomatic benign prostatic hyperplasia in men with an enlarged prostate, where it improves symptoms and reduces the risk of acute urinary retention and of surgery [4]. In the 4-year PLESS trial of 3,040 men aged 45 to 78, acute urinary retention developed in 3% of men on finasteride versus 7% on placebo, a 57% reduction in risk (95% CI 40 to 69) [6]. The Propecia label gives only 1 mg once daily for hair loss and describes the 5 mg dose as five times the hair-loss dose when it discusses prostate cancer risk [1]. BPH trials enrolled men in their mid-40s and older, so the 5 mg evidence base does not describe men in their twenties [4][6].

What sexual side effects appear in the first year?

In the three 12-month controlled hair-loss trials — 945 men on 1 mg and 934 on placebo, aged 18 to 41 — drug-related decreased libido was reported by 1.8% versus 1.3%, erectile dysfunction by 1.3% versus 0.7%, and ejaculation disorder by 1.2% versus 0.7% [1]. One or more of these occurred in 3.8% (36 of 945) versus 2.1% (20 of 934), p=0.04, and discontinuation for drug-related sexual events was 1.2% versus 0.9% [1]. The incidence of each reaction fell to 0.3% or less by the fifth year of treatment [1]. A self-administered sexual function questionnaire at month 12 favoured placebo in 3 of 4 domains — sexual interest, erections, and perception of sexual problems — with no significant difference in overall satisfaction with sex life [1].

A 2019 meta-analysis in Acta Derm Venereol pooled 15 randomized placebo-controlled trials in 4,495 men with androgenetic alopecia: relative risk of sexual dysfunction was 1.57 (95% CI 1.19 to 2.08) for 5-alpha reductase inhibitors overall and 1.66 (1.20 to 2.30) for finasteride 1 mg alone [7].

The Propecia label's postmarketing section lists sexual dysfunction that continued after discontinuation, including erectile dysfunction, libido disorders, ejaculation disorders and orgasm disorders [1]. Those reports are voluntary, come from a population of uncertain size, and the label states that a causal relationship cannot reliably be established [1].

Does finasteride change sperm or fertility?

In the 1 mg data, median ejaculate volume changed by -0.3 mL (-11%) on finasteride versus -0.2 mL (-8%) on placebo after 48 weeks [1]. The label also lists male infertility and/or poor seminal quality as postmarketing reports, noting that normalization or improvement in seminal quality has been reported after discontinuation [1]. The 5 mg semen study in Proscar's label, run over 24 weeks in healthy volunteers, found no clinically meaningful effect on sperm concentration, motility, morphology or pH, but a median 0.6 mL (22.1%) fall in ejaculate volume that was reversible, with an average 84 weeks to return to baseline [4].

What does the label say about mood?

The Propecia label's postmarketing section lists depression, suicidal ideation and behavior, with the caveat that voluntary reports from an uncertain-size population cannot establish cause [1]. The Proscar label also lists depression and suicidal ideation as postmarketing reports [4]. Neither Propecia nor Proscar carries a boxed warning for depression, suicidal ideation or sexual dysfunction [1][4].

Two large cohort studies looked at suicide and depression in men starting 5-alpha reductase inhibitors, and both were built from older prostate patients. In Ontario, 93,197 men aged 66 or older showed no increase in suicide (HR 0.88, 95% CI 0.53 to 1.45); self-harm was raised only in the first 18 months (HR 1.88, 95% CI 1.34 to 2.64), and depression was higher in the first 18 months (HR 1.94, 95% CI 1.73 to 2.16) and remained higher afterward (HR 1.22, 95% CI 1.08 to 1.37) [12]. In Sweden, among 2,236,876 men aged 50 to 90, of whom 70,645 started finasteride at a median age of 73, depression was higher on finasteride (HR 1.61, 1.48 to 1.75) while suicide was not associated (HR 1.22, 0.99 to 1.49) [13]. Neither cohort describes a man in his twenties taking 1 mg for hair loss.

Does finasteride affect PSA in a young man?

Yes, and the effect is measurable even at 1 mg. In clinical studies with Propecia in men aged 18 to 41, mean serum PSA fell from 0.7 ng/mL at baseline to 0.5 ng/mL at month 12 [1]. The Propecia label says a confirmed rise from the lowest PSA value during treatment may signal prostate cancer, even when the result remains within the usual range [1]. Proscar's label puts the reduction at about 50% within six months and says an isolated PSA in a man treated for six months or more should be doubled for comparison with normal ranges; percent free PSA stays constant [4].

Tablet handling in pregnancy

Finasteride is contraindicated in pregnancy. The Propecia label warns that pregnant women and women who may become pregnant should not handle crushed or broken tablets because finasteride may affect the external genitalia of a male fetus; the tablets are coated, which prevents contact with the active ingredient during normal handling as long as they are intact [1].

Lower doses, every-other-day dosing and topical finasteride

The label gives one hair-loss regimen: 1 mg once daily [1]. It does not describe alternate-day dosing or a lower dose for hair loss. No topical finasteride is FDA-approved; Drugs@FDA lists only oral finasteride tablets [3][5]. One small pharmacokinetic study tested an investigational 0.25% topical solution: 24 healthy men with androgenetic alopecia used either the topical solution twice daily or the 1 mg tablet daily for 7 days, plasma DHT fell by roughly 68 to 75% with the topical solution and 62 to 72% with the tablet, and plasma finasteride exposure was far lower with the topical product (p<0.0001) [14].